ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
136.65
+1.72 (1.27%)
At close: Jun 5, 2026, 4:00 PM EDT
136.61
-0.04 (-0.03%)
After-hours: Jun 5, 2026, 5:22 PM EDT
ICU Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 288.33 | 307.96 | 308.57 | 254.22 | 208.78 | 552.83 |
Short-Term Investments | - | - | - | 0.5 | 4.22 | 14.42 |
Cash & Short-Term Investments | 288.33 | 307.96 | 308.57 | 254.72 | 213.01 | 567.25 |
Cash Growth | -0.47% | -0.19% | 21.14% | 19.58% | -62.45% | 38.09% |
Accounts Receivable | 201.08 | 180.52 | 182.83 | 161.57 | 221.72 | 105.89 |
Inventory | 605.59 | 615.86 | 584.68 | 709.36 | 696.01 | 290.24 |
Other Current Assets | 118.25 | 86.22 | 365.91 | 95.62 | 104.46 | 66.43 |
Total Current Assets | 1,213 | 1,191 | 1,442 | 1,221 | 1,235 | 1,030 |
Net Property, Plant & Equipment | 495.93 | 506.29 | 496.04 | 682.82 | 710.98 | 508.21 |
Other Intangible Assets | 598.97 | 633.56 | 740.79 | 870.59 | 982.77 | 188.31 |
Goodwill | 1,486 | 1,500 | 1,433 | 1,472 | 1,449 | 43.44 |
Long-Term Investments | 130.92 | 131.59 | 3.04 | - | 0.52 | 4.62 |
Other Long-Term Assets | 89.14 | 88.77 | 89.31 | 131.32 | 136.93 | 106.35 |
Total Assets | 4,014 | 4,051 | 4,204 | 4,378 | 4,516 | 1,881 |
Accounts Payable | 173.98 | 154.37 | 148.02 | 150.03 | 215.9 | 81.13 |
Accrued Expenses | 314.57 | 315.34 | 306.92 | 268.22 | 242.77 | 118.2 |
Current Portion of Long-Term Debt | 18.75 | 18.75 | 51 | 51 | 29.69 | - |
Other Current Liabilities | 10.6 | 10.4 | 50.24 | 12.59 | 6.2 | 1.45 |
Total Current Liabilities | 517.9 | 498.86 | 556.18 | 481.84 | 494.56 | 200.78 |
Long-Term Debt | 1,262 | 1,266 | 1,532 | 1,578 | 1,624 | - |
Other Long-Term Liabilities | 122.11 | 161.91 | 150.66 | 195.42 | 307.48 | 63.93 |
Total Long-Term Liabilities | 1,384 | 1,428 | 1,683 | 1,773 | 1,931 | 63.93 |
Total Liabilities | 1,902 | 1,927 | 2,239 | 2,255 | 2,426 | 264.71 |
Common Stock | 2.52 | 2.47 | 2.45 | 2.41 | 2.4 | 2.13 |
Treasury Stock | -25.18 | -0.02 | -0.09 | -0.26 | -0.24 | -0.03 |
Additional Paid-in Capital | 1,465 | 1,465 | 1,412 | 1,366 | 1,331 | 721.41 |
Accumulated Other Comprehensive Income | -51.9 | -34.63 | -139.4 | -53.08 | -80.98 | -19.27 |
Retained Earnings | 721.02 | 690.89 | 690.16 | 807.85 | 837.5 | 911.79 |
Shareholders' Equity | 2,112 | 2,124 | 1,965 | 2,123 | 2,090 | 1,616 |
Total Liabilities & Equity | 4,014 | 4,051 | 4,204 | 4,378 | 4,516 | 1,881 |
Total Debt | 1,281 | 1,285 | 1,583 | 1,629 | 1,653 | 0 |
Net Cash (Debt) | -992.25 | -976.7 | -1,274 | -1,374 | -1,440 | 567.25 |
Net Cash Growth | - | - | - | - | - | 38.09% |
Net Cash Per Share | -39.98 | -39.22 | -52.25 | -57.04 | -60.35 | 26.04 |
Book Value | 2,112 | 2,124 | 1,965 | 2,123 | 2,090 | 1,616 |
Book Value Per Share | 85.10 | 85.28 | 80.58 | 88.14 | 87.56 | 74.19 |
Tangible Book Value | 27.4 | -9.49 | -208.33 | -219.62 | -342.1 | 1,384 |
Tangible Book Value Per Share | 1.10 | -0.38 | -8.54 | -9.12 | -14.33 | 63.55 |